An inflammation-associated lncRNA induces neuronal damage via mitochondrial dysfunction.

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Non-coding SNPs linked to immune diseases often reside in regulatory elements like long non-coding RNAs (lncRNAs).
• lncRNAs are implicated in various cellular functions, making them potential therapeutic targets.
• The lncRNA LOC339803, located in an autoimmunity-associated region, has a known proinflammatory role in intestinal disorders.

Purpose of the Study:

• To investigate the function of lncRNA LOC339803 specifically within neuronal cells.
• To explore the role of LOC339803 in the pathogenesis of multiple sclerosis (MS).

Main Methods:

• Analysis of human brain samples.
• Application of diverse in vitro techniques to study lncRNA function.
• Assessment of hexokinase 2 (HK2) levels and mitochondrial integrity.

Main Results:

• Demonstrated a distinct function of LOC339803 in neuronal cells.
• Showed that LOC339803 maintains hexokinase 2 (HK2) levels, preserving mitochondrial integrity.
• Partially elucidated the involvement of LOC339803 in the pathogenesis of multiple sclerosis (MS).

Conclusions:

• Highlights the necessity of cell-type-specific investigations for regulatory lncRNAs.
• Identifies LOC339803 as a potential biomarker for mitochondrial dysfunction in neurodegenerative diseases.
• Proposes LOC339803 as a candidate for therapeutic intervention in neurodegeneration.